205 related articles for article (PubMed ID: 23644821)
1. The protective effect of recombinant FomA-expressing Lactobacillus acidophilus against periodontal infection.
Ma L; Ding Q; Feng X; Li F
Inflammation; 2013 Oct; 36(5):1160-70. PubMed ID: 23644821
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein.
Ma L; Li F; Zhang X; Feng X
Arch Oral Biol; 2018 Aug; 92():25-31. PubMed ID: 29747062
[TBL] [Abstract][Full Text] [Related]
3. [Acquisition and the immunogenicity of the outer membrane FomA protein of
Ma L; Feng XP; Wu QL; Zhang XY; Zhang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Oct; 53(10):674-680. PubMed ID: 30392224
[No Abstract] [Full Text] [Related]
4. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.
Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM
Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489
[TBL] [Abstract][Full Text] [Related]
5. Immunological Pathways Triggered by
de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
[No Abstract] [Full Text] [Related]
6. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
Nakagaki H; Sekine S; Terao Y; Toe M; Tanaka M; Ito HO; Kawabata S; Shizukuishi S; Fujihashi K; Kataoka K
Infect Immun; 2010 Mar; 78(3):1185-92. PubMed ID: 20008529
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341
[TBL] [Abstract][Full Text] [Related]
8. Heat-killed Lactobacillus acidophilus mediates Fusobacterium nucleatum induced pro-inflammatory responses in epithelial cells.
Ding Q; Sun X; Cao S; Zhao C; Wang Y; Wang X
FEMS Microbiol Lett; 2021 Apr; 368(5):. PubMed ID: 33693760
[TBL] [Abstract][Full Text] [Related]
9. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
10. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
[TBL] [Abstract][Full Text] [Related]
11. Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection.
Polak D; Naddaf R; Shapira L; Weiss EI; Houri-Haddad Y
J Periodontol; 2013 Jul; 84(7):1019-25. PubMed ID: 23030239
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.
Onoue S; Imai T; Kumada H; Umemoto T; Kaca W; Isshiki Y; Kaneko A; Kawahara K
Microbiol Immunol; 2003; 47(1):51-5. PubMed ID: 12636253
[TBL] [Abstract][Full Text] [Related]
13. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis.
Choi J; Borrello MA; Smith E; Cutler CW; Sojar H; Zauderer M
Oral Microbiol Immunol; 2001 Dec; 16(6):338-44. PubMed ID: 11737656
[TBL] [Abstract][Full Text] [Related]
14. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection.
Polak D; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2012 Jul; 39(7):617-25. PubMed ID: 22607053
[TBL] [Abstract][Full Text] [Related]
15. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
Liu PF; Huang IF; Shu CW; Huang CM
Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
[TBL] [Abstract][Full Text] [Related]
16. Virulence mechanism of bacteria in mixed infection: attenuation of cytokine levels and evasion of polymorphonuclear leukocyte phagocytosis.
Polak D; Shapira L; Weiss EI; Houri-Haddad Y
J Periodontol; 2013 Oct; 84(10):1463-8. PubMed ID: 23259412
[TBL] [Abstract][Full Text] [Related]
17. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with peritonsillar cellulitis and abscess.
Brook I; Foote PA; Slots J
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S220-1. PubMed ID: 7548558
[No Abstract] [Full Text] [Related]
18. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X; LaRosa KB; Kawai T; Taubman MA
Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
[TBL] [Abstract][Full Text] [Related]
19. Synergistic pathogenicity of Porphyromonas gingivalis and Fusobacterium nucleatum in the mouse subcutaneous chamber model.
Metzger Z; Lin YY; Dimeo F; Ambrose WW; Trope M; Arnold RR
J Endod; 2009 Jan; 35(1):86-94. PubMed ID: 19084132
[TBL] [Abstract][Full Text] [Related]
20. The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity.
Toussi DN; Liu X; Massari P
Clin Vaccine Immunol; 2012 Jul; 19(7):1093-101. PubMed ID: 22623652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
